Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2000
Clinical utility of testing human immunodeficiency virus for drug resistanceP R Harrigan, H C CôtéJournal of Virology|April 29, 1998
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitroP R Harrigan, S Bloor, B A LarderAIDS (London, England)|June 17, 1999
Rate of HIV-1 RNA rebound upon stopping antiretroviral therapyP R Harrigan, M Whaley, J S MontanerJournal of Virology|January 3, 2001
Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavirH C Côté, Z L Brumme, P R HarriganScience (New York, N.Y.)|August 4, 1995
Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapyB A Larder, S D Kemp, P R HarriganChemistry and Physics of Lipids|January 1, 1990
Protection of liposomes during dehydration or freezingP R Harrigan, T D Madden, P R CullisBiophysical Journal|November 1, 1992
Determination of transmembrane pH gradients and membrane potentials in liposomesP R Harrigan, M J Hope, T E Redelmeier, et al.Biophysical Journal|January 1, 1992
Uptake of basic amino acids and peptides into liposomes in response to transmembrane pH gradientsA C Chakrabarti, I Clark-Lewis, P R Harrigan, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 28, 2017
Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996-2016G Rocheleau, C J Brumme, J Shoveller, et al.Pageof 6